NSEMemorandum of Understanding/Agreements4 Aug 2026 · 4 Aug 2026, 07:28 pm

Memorandum of Understanding/Agreements

Healthcare Global Enterprises Limited · HCG

✦ AI SummaryM&A

Healthcare Global Enterprises Limited has entered into an agreement to acquire a 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited through the subscription of equity shares for an aggregate consideration of INR 38 lakh.

Analysis Scores

Earnings Impact2/10
Growth Catalyst6/10
Governance Concern1/10
Regulatory Risk3/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations ), we would like to inform that HCG Manavata Oncology LLP ( LLP ), a subsidiary LLP of Healthcare Global Enterprises Limited ( Company ) has entered into an agreement to acquire 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited ( EVRE ) through subscription of equity shares for an aggregate consideration of INR 38 lakh to qualify as a captive user of the power plant operated by EVRE.

Attachments (1)

📄

HCG1_04082026192752_Disclosure_HCG_Manvata_Acquisition.pdf

pdf

Download →
View document text
August 04, 2026 National Stock Exchange of India Limited, BSE Limited, Compliance Department, Compliance Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (East), Mumbai - 400051, Dalal Street, Mumbai - 400001, Maharashtra, India Maharashtra, India Dear Sir/Madam, Subject : Intimation under Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Stock Code : BSE – 539787, NSE – HCG Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), we would like to inform that HCG Manavata Oncology LLP (“LLP”), a subsidiary LLP of Healthcare Global Enterprises Limited (“Company”) has entered into an agreement to acquire 26% equity stake in Epic Vighnaharta Renewable Energy Private Limited (“EVRE”) through subscription of equity shares for an aggregate consideration of INR 38 lakh. Following the completion of the acquisition, the LLP will hold a 26% stake in EVRE, on a fully diluted basis, and consequently, the Company will have an indirect interest of up to 26% in EVRE. We are enclosing herewith the brief details of the above as prescribed under SEBI Listing Regulations, read with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026, in respect of the aforesaid entity as Annexure A. We would request you to please take note of the above and bring the same to the notice of all concerned. The above information is also available on the website of the Company at: https://www.hcgoncology.com Thanking you, For HealthCare Global Enterprises Limited Sunu Manuel Company Secretary & Compliance Officer Encl: a/a HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag Annexure A Relevant details under amended Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read along with the SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. Sr. Particulars Details of Epic Vighnaharta Renewable Energy No. Private Limited 1. Name of the Target Company, Name: Epic Vighnaharta Renewable Energy Private details in brief such as size, Limited (“EVRE”) turnover, etc. Brief Details: EVRE is primarily engaged in the business of power generation from renewable power plants. Authorized Share Capital (FY26): ₹ 1,00,000 Revenue from Operations (FY26): ₹ NIL 2. Whether the acquisition would fall No, the transaction does not fall within the ambit of within the related party a related party transaction. The LLP, which is a transaction(s) and whether the subsidiary of the Company, proposes to acquire a promoter /promoter group/ group stake of 26% in EVRE. Except to the extent of companies have any interest in the indirect interest in EVRE through the LLP, neither entity being acquired? the promoter/promoter group nor any group company has any direct interest in EVRE. If yes, nature of interest and details thereof and whether the same is done at "arm’s length" 3. Industry to which the entity being Power Generation and Clean Energy Development acquired belongs 4. Objects and impact of acquisition EVRE is a power project developer, which is setting (including but not limited to, up a solar power plant in Mangalwedha, District disclosure of reasons for Solapur, in the State of Maharashtra. The LLP would acquisition of target entity, if its acquire 26% stake in EVRE to qualify as a captive business is outside the main line of user of the power plant operated by EVRE, so that business of the listed entity) EVRE can supply the electricity generated by its plant to the LLP for its own use. HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag 5. Brief details of any governmental No specific governmental or regulatory approvals or regulatory approvals required are required for incorporation, except such for the acquisition approvals, registrations or licenses as may be required in the ordinary course of business. 6. Indicative time period for The acquisition is expected to be completed in Q2 completion of the acquisition FY 2027 upon fulfilment of the terms and conditions stipulated under the agreement executed for the acquisition of stake in EVRE by the LLP. 7. Consideration - whether Cash Cash Consideration consideration or share swap or any other form and details of the same 8. Cost of acquisition and/or the Cost of acquisition- INR 38 lakh price at which shares are acquired 9. Percentage of shareholding/ 3,80,000 Equity Shares of INR 10 each constituting control acquired and/ or number of 26% of share capital of EVRE. shares acquired 10. Brief background about the entity EVRE was incorporated on March 22, 2025, as per acquired in terms of product/line the provisions of the Companies Act, 2013, bearing of and business acquired, date of corporate identification number incorporation, history of last 3 U35105MH2025PTC443553 and having its years turnover, country in which registered office at A-105B, Gokul Arcade, Swami the acquired entity has presence Nityanand Marg, Vile Parle East, Mumbai 400053. and any other significant information (in brief) EVRE is a power project developer and is setting up a solar power plant in Mangalwedha, District Solapur, in the State of Maharashtra, with an initial capacity of 1.3 MWp. Date of incorporation – March 22, 2025 EVRE has presence in India. EVRE’s Revenue from Operations in last 3 years – FY25-26: INR NIL FY24-25: INR NIL FY23-24: INR NIL HealthCare Global Enterprises Limited Reg Off: HCG Towers #8, P. Kalinga Rao Road, Sampangi Ram Nagar, Bengaluru - 560 027, Karnataka, India Corp Off: #3, G-Floor, Tower Block, Unity Buildings Complex, Mission Road, Bengaluru - 560 027, Karnataka, India 91 80 4660 7700 | Email-query@hcgel.com | Website - www.hcgoncology.com | CIN: L15200KA1998PLC023489 Ahmedabad | Bengaluru | Bhavnagar | Chennai | Cuttack | Hubballi | Indore | Jaipur | Kalaburagi | Kenya | Kolkata | Mumbai | Nagpur | Nashik | Ongole | Rajkot | Ranchi | Shimoga | Vadodara | Vijayawada | Vizag